Natural Nutraceuticals in Actual Therapeutic Strategies

A special issue of Nutraceuticals (ISSN 1661-3821).

Deadline for manuscript submissions: closed (1 September 2023) | Viewed by 36398

Image courtesy of BioRender

Special Issue Editor

Special Issue Information

Dear Colleagues,

Nutraceuticals are used to combat and amelioriate the effects of chronic diseases, especially those associated with degenerative diseases. The concept of nutraceuticals is attributed to a product, usually an extract, that contains several bioactive compounds with various biological effects. Reducing oxidative stress and inflammatory processes are strategies in using these products to maintain homeostasis. Other products such as royal jelly or polysaccharides from mushrooms also support the normal functioning of the nervous system, which influences the long-term state of homeostasis. Maintaining the body's general health through natural products with nutraceutical functions is the main target of this volume. This can be achieved by using a wide range of products and by modulating physiological functions that reduce oxidative stress, inflammatory processes, or the modulation of human microbiota. These are just examples of the targets that natural nutraceuticals can have.

Prof. Dr. Emanuel Vamanu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutraceuticals is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • modulation
  • enriched probiotic biomass
  • anti-age
  • bee products
  • modulation process
  • natural pharmaceutical products
  • new therapeutic targets
  • inflammatory processes
  • bioactive compounds
  • degenerative processes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (10 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1958 KiB  
Article
Herbal Infusions as a Part of the Mediterranean Diet and Their Association with Psychological Resilience: The Paradigm of Greek Mountain Tea
by Efstratios Christodoulou, Ana Meca and Antonios E. Koutelidakis
Nutraceuticals 2023, 3(3), 438-450; https://doi.org/10.3390/nutraceuticals3030032 - 1 Sep 2023
Cited by 5 | Viewed by 3133
Abstract
Herbal infusions (HI) are a popular type of beverage known for their potential health benefits due to the extraction of phytochemicals and bioactive compounds. The Mediterranean Diet (MD) is a well-known dietary pattern with beneficial effects on health, and Psychological Resilience (PsyR) is [...] Read more.
Herbal infusions (HI) are a popular type of beverage known for their potential health benefits due to the extraction of phytochemicals and bioactive compounds. The Mediterranean Diet (MD) is a well-known dietary pattern with beneficial effects on health, and Psychological Resilience (PsyR) is a key indicator of mental health and human well-being. The aim of this cross-sectional study was to explore the relationship between HI and the MD, as well as their association with PsyR. The study included 398 healthy adults from Greece who participated voluntarily in an online research survey. The results indicated that 45.9% of participants consumed HI more than twice per week. There was a statistically significant association between the weekly consumption of HI and the Mediterranean Diet Adherence Screener (14-MEDAS), which identified HI consumption as a prognostic factor of high adherence to the MD. Additionally, HI consumption was significantly associated with PsyR. St John’s wort, green tea, and Greek mountain tea were associated with higher levels of PsyR. Greek mountain tea was also associated with a healthful and sustainable lifestyle. These findings suggest that HI are an integral part of the Mediterranean Diet, and their consumption is associated with PsyR. Promoting the consumption of HI such as Greek mountain tea and other herbs could be an effective way to promote healthy lifestyle behaviors and sustainable practices. Further randomized control trials are needed to confirm the results of this study. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Figure 1

17 pages, 3572 KiB  
Communication
Effects of a Standardized Hydrogenated Extract of Curcumin (Curowhite™) on Melanogenesis: A Pilot Study
by Shilpi Goenka
Nutraceuticals 2023, 3(3), 421-437; https://doi.org/10.3390/nutraceuticals3030031 - 10 Aug 2023
Cited by 3 | Viewed by 2970
Abstract
The stimulation of melanogenesis by novel natural products is desirable for cosmetic applications such as skin tanning, anti-greying, and clinical use for treating vitiligo and leukoderma disorders. Microphthalmia transcription factor (MITF) is a central transcription factor that controls the expression of tyrosinase, which [...] Read more.
The stimulation of melanogenesis by novel natural products is desirable for cosmetic applications such as skin tanning, anti-greying, and clinical use for treating vitiligo and leukoderma disorders. Microphthalmia transcription factor (MITF) is a central transcription factor that controls the expression of tyrosinase, which is a key enzyme responsible for catalyzing the rate-limiting processes of melanin production. Tetrahydrocurcuminoids (THCr), which mostly consist of tetrahydrocurcumin (THC), are a colorless bioactive mixture derived from curcuminoids that are extracted from the Curcuma longa plant. THCr has been reported to exhibit superior properties, including antioxidant and anti-inflammatory effects. Our previous study reported the greater melanogenesis-stimulating effects of purified THC, compared to hexahydrocurcumin (HHC) or octahydrocurcumin (OHC). Curowhite™ (CW) is a proprietary extract that consists of 25% hydrogenated curcuminoids (mixture of THCr, hexahydrocurcuminoids, and octahydrocurcuminoids) encapsulated in a β-cyclodextrin (βCyD) excipient. The encapsulation of THCr in a suitable excipient, such as the widely popular cyclodextrins, helps to enhance the stability, solubility, and bioavailability of the THCr. CW is marketed as a nutraceutical with GRAS status and is safe when administered orally, as shown in vivo studies. However, the impact of CW on melanogenesis remains unexplored. Herein, the impact of CW on melanogenesis were investigated using B16F10 and MNT-1 cells. Our findings show that CW is markedly cytotoxic to B16F10 cells without affecting the cellular melanin content. However, in MNT-1 cells, CW significantly stimulated intracellular melanin content over the concentration range (20–60 µg/mL) with increased dendrite formation while being nontoxic to MNT-1 cells or HaCaT cells after a 5-day treatment. Examination of the effects of the excipient βCyD on cytotoxicity and melanogenesis confirmed that the excipient had no contribution to the biological impacts that were found to be exclusively attributable to the encapsulated mixture (THCr). The mechanisms of CW’s promelanogenic effects in MNT-1 cells were found to be related, at least in part, to an increase in tyrosinase and MITF protein levels, as CW did not alter tyrosinase activity in MNT-1 cells. Moreover, CW exhibited antioxidant activity as obtained through DPPH radical scavenging assay. Together, the findings of this pilot study indicate that CW might hold an exciting avenue as a pro-pigmenting nutraceutical for treating hypopigmentation disorders, the detailed mechanisms of which warrant further exploration. Moreover, future investigations are necessary to examine CW’s effects on melanogenesis in normal human melanocytes and in vivo studies. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

9 pages, 933 KiB  
Communication
Exploring the Efficacy of Extracts for Cosmetic Creams: In Vivo and In Vitro Assessments
by Cristina Monica Papa, Alexandru Suciu, Ioan Dopcea, Nicoleta Ene, Sandeep Kumar Singh and Emanuel Vamanu
Nutraceuticals 2023, 3(3), 306-314; https://doi.org/10.3390/nutraceuticals3030024 - 30 Jun 2023
Cited by 2 | Viewed by 2531
Abstract
Plants with therapeutic potential are a rich resource for the inhabitants of a country, with Romania among them, having a diverse flora not only from plants but also from fungi. New trends in biopharmaceuticals are also addressed in studies related to topical administration, [...] Read more.
Plants with therapeutic potential are a rich resource for the inhabitants of a country, with Romania among them, having a diverse flora not only from plants but also from fungi. New trends in biopharmaceuticals are also addressed in studies related to topical administration, representing a great advantage; research has determined biological activities in vivo and in vitro. This study aimed to present the main active compounds from extracts of Lactarius piperatus, Centaurea cyanus, and Ribes rubrum. In vitro (DPPH scavenging activity and reducing power) and in vivo activities were determined. A survey of hydrating cosmetic products and the completion of a patch test (in vivo test) under dermatological control were realized to confirm the skin compatibility of the product in a panel of human subjects after a single application. The cosmetic product did not induce allergic reactions, erythema, irritation, or itching. This study showed that the extracts incorporated in the formulation of the face cream had a nutricosmetic effect. The research demonstrated a result of increasing skin elasticity and an anti-inflammatory effect following direct application to the skin of volunteers. The product offered in vitro/in vivo protection against the action of free radicals; it was effective in reducing the side effects of exposure to the action of blue light. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

10 pages, 930 KiB  
Article
Anti-Inflammatory Effects, Protection of Gut Barrier Integrity and Stimulation of Phagocytosis of Postbiotic Combination ABB C1
by Maria Tintoré, Jordi Cuñé, Vaclav Vetvicka and Carlos de Lecea
Nutraceuticals 2023, 3(1), 109-118; https://doi.org/10.3390/nutraceuticals3010009 - 2 Feb 2023
Cited by 1 | Viewed by 2803
Abstract
This study evaluated the anti-inflammatory effects, the protection of gut barrier integrity, and the stimulation of phagocytosis in peripheral cells of a nutritional supplement based on a synergistic combination of yeast-based ingredients with a unique 1,3/1,6-glucan complex and a consortium of postbiotic Saccharomyces [...] Read more.
This study evaluated the anti-inflammatory effects, the protection of gut barrier integrity, and the stimulation of phagocytosis in peripheral cells of a nutritional supplement based on a synergistic combination of yeast-based ingredients with a unique 1,3/1,6-glucan complex and a consortium of postbiotic Saccharomyces cerevisiae rich in selenium and zinc. The anti-inflammatory effect in caco-2 cells in the presence and absence of a pro-inflammatory challenge (tumour necrosis factor alpha [TNF-α]/interferon gamma [IFN-ɣ]) showed statistically significant reductions in IFN-ɣ induced protein-10 (IP-10), and monocyte chemoattractant protein-1 (MCP-1) levels vs. controls (p < 0.001). Disruption of the gut integrity in the presence or absence of Escherichia coli (ETEC H10407) showed transepithelial electrical resistance (TEER) values higher in the ABB C1® group after 6 h of testing. Spontaneous build-up of the gut epithelium monolayer over 22 days was also greater in the ABB C1® condition vs. a negative control. ABB C1® showed a significantly higher capacity to stimulate phagocytosis as compared with controls of algae β-1,3-glucan and yeast β-1,3/1,6 glucan (p < 0.001). This study supports the mechanism of action by which ABB C1® may improve the immune response and be useful to prevent infection and allergy in clinical practice. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Figure 1

16 pages, 2365 KiB  
Article
Amber Extract Suppressed Mast Cell-Mediated Allergic Inflammation via the Regulation of Allergic Mediators—An In Vitro Study
by Redoyan Refli, Neng Tanty Sofyana, Haruna Haeiwa, Reiko Takeda, Kazuma Okazaki, Marie Sekita and Kazuichi Sakamoto
Nutraceuticals 2023, 3(1), 75-90; https://doi.org/10.3390/nutraceuticals3010006 - 12 Jan 2023
Cited by 2 | Viewed by 3333
Abstract
The various clinical approaches for treating allergy-related diseases have shown modest progress in low side effects and improved clinical outcomes. Therefore, finding alternative anti-allergic agents is crucial. The present study explored the anti-allergic effects of amber extract (fossilized tree resin) in RBL-2H3 mast [...] Read more.
The various clinical approaches for treating allergy-related diseases have shown modest progress in low side effects and improved clinical outcomes. Therefore, finding alternative anti-allergic agents is crucial. The present study explored the anti-allergic effects of amber extract (fossilized tree resin) in RBL-2H3 mast cells stimulated with different allergens. In order to support the information on the inflammatory effect of the amber extract, NO production analysis on RAW 264.7 cells was conducted. β-Hexosaminidase release, an indicator of the efficacy of the amber extract in preventing mast cell activation and degranulation, reactive oxygen species (ROS) generation, and the effect of the amber extract on key cytokines production on RBL-2H3 cells, was evaluated. The results demonstrated that amber extract at concentrations up to 50 μg/mL had no cytotoxic effect on RAW 264.7 and RBL-2H3 cells. Amber extract inhibited NO production in RAW 264.7 cells. Treatment with amber extract significantly suppressed the release of β-hexosaminidase, especially at 50 μg/mL. Furthermore, amber extract suppressed the significantly increased ROS levels induced by allergen stimulation and allergy-associated cytokines. The results also suggested that amber extract exerts anti-allergic inflammatory effects by inhibiting the MAPK and NF-κB signaling pathways, resulting in decreased cytokines production. Thus, the amber extract is a promising anti-allergic agent. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

Review

Jump to: Research

14 pages, 687 KiB  
Review
Medicinal Properties of Honey and Cordyceps Mushrooms
by Theodor-Ioan Badea and Emanuel Vamanu
Nutraceuticals 2023, 3(4), 499-512; https://doi.org/10.3390/nutraceuticals3040036 - 10 Oct 2023
Viewed by 2743
Abstract
In a world still recovering after the COVID-19 pandemic, the consequences of which are still not entirely known, the attention of scientists worldwide is drawn to natural products with positive effects on immunity. The starting point for tackling such a subject is proper [...] Read more.
In a world still recovering after the COVID-19 pandemic, the consequences of which are still not entirely known, the attention of scientists worldwide is drawn to natural products with positive effects on immunity. The starting point for tackling such a subject is proper documentation of substances used in traditional medicine, which usually have significant nutritional and functional values. Among the most well-known of these substances are mushrooms and honey, both of which have been used for thousands of years all around the globe. The following work aims to gather information about the properties of honey and Cordyceps sp. mushrooms by studying the scientific literature available at this point. With the proper use of this information, it will be possible to develop products that incorporate the studied ingredients to increase their functional and medicinal value. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Figure 1

17 pages, 3085 KiB  
Review
Bioactive Lignans from Flaxseed: Biological Properties and Patented Recovery Technologies
by Paola Sangiorgio, Simona Errico, Alessandra Verardi, Stefania Moliterni, Gabriella Tamasi, Claudio Rossi and Roberto Balducchi
Nutraceuticals 2023, 3(1), 58-74; https://doi.org/10.3390/nutraceuticals3010005 - 10 Jan 2023
Cited by 7 | Viewed by 6811
Abstract
Flaxseed lignans frequently feature in the literature. However, much remains to be discovered about the mechanisms underlying their functional and therapeutic properties. Furthermore, it is necessary to identify systems for lignan production and detoxification that are sustainable, cost-effective, easy to use, and scale [...] Read more.
Flaxseed lignans frequently feature in the literature. However, much remains to be discovered about the mechanisms underlying their functional and therapeutic properties. Furthermore, it is necessary to identify systems for lignan production and detoxification that are sustainable, cost-effective, easy to use, and scale up. These systems can address the needs of the nutraceutical, cosmetic, and pharmaceutical sectors and lead to competitive commercial products. This review analyzes the biological effects of lignans as anticancer, antioxidants, and modulators of estrogen activity. It also focuses on the most recent articles on lignan extraction methods that are sustainable and suitable as products for human consumption. Furthermore, the most up-to-date and relevant patents for lignan recovery are examined. The search and selection methodology for articles and patents was conducted using the most popular bibliographic and patent databases (e.g., Scopus, Pubmed, Espacenet). To the best of our knowledge, this is the first overview that details the patented technologies developed in the flaxseed lignans area in the last 10 years. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Figure 1

20 pages, 1110 KiB  
Review
Understanding the Molecular Mechanisms Underlying the Analgesic Effect of Ginger
by Corina Andrei, Anca Zanfirescu, George Mihai Nițulescu and Simona Negreș
Nutraceuticals 2022, 2(4), 384-403; https://doi.org/10.3390/nutraceuticals2040029 - 24 Nov 2022
Cited by 3 | Viewed by 4928
Abstract
Chronic pain has a high prevalence and a profound impact on patients and society, and its treatment is a real challenge in clinical practice. Ginger is emerging as a promising analgesic—effective against various types of pain and well-tolerated by patients. However, we are [...] Read more.
Chronic pain has a high prevalence and a profound impact on patients and society, and its treatment is a real challenge in clinical practice. Ginger is emerging as a promising analgesic—effective against various types of pain and well-tolerated by patients. However, we are just beginning to understand its complex mechanism of action. A good understanding of its mechanism would allow us to fully utilize the therapeutical potential of this herbal medicine as well as to identify a better strategy for treating chronic pain. To provide this information, we searched PubMed, SCOPUS, and Web of Science for in vitro studies or animal experiments investigating the analgesic effect of ginger extract or its components. The analysis of data was carried out in the form of a narrative review. Our research indicates that ginger extract, through its various active ingredients, suppresses the transmission of nociceptive signals while activating the descendent inhibitory pathways of pain. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

15 pages, 1991 KiB  
Review
Arctium lappa Lam. and Its Related Lignans Improve Hyperglycemia and Dyslipidemia in Diabetic Rodent Models: A Systematic Review and Meta-Analysis
by Shihori Watanabe, Shizuko Yamabe and Masako Shimada
Nutraceuticals 2022, 2(4), 335-349; https://doi.org/10.3390/nutraceuticals2040026 - 11 Nov 2022
Cited by 4 | Viewed by 2599
Abstract
Research on nutraceuticals has focused on reducing the onset, progression, and significant consequences of diabetes mellitus. Arctium lappa Lam. is a great source of plant fibers and polyphenols that have anti-disease benefits, including those for diabetes mellitus. This study sought to determine the [...] Read more.
Research on nutraceuticals has focused on reducing the onset, progression, and significant consequences of diabetes mellitus. Arctium lappa Lam. is a great source of plant fibers and polyphenols that have anti-disease benefits, including those for diabetes mellitus. This study sought to determine the impact of Arctium lappa Lam. extracts and its associated lignans on diabetic hyperglycemia and dyslipidemia by conducting meta-analyses of the available research using diabetic rodents. English-language peer-reviewed articles were searched by PubMed and Embase up until 10 August 2022. Included were studies comparing the blood glucose and/or lipid levels of diabetic rodents given either extracts of Arctium lappa Lam. and its related lignans or vehicles. Blood glucose levels were reported in 16 studies involving 168 diabetic mice or rats treated with Arctium lappa Lam. and 168 diabetic controls. The pooled effect size was −1.42 [95% CI: −1.84 to −1.00] with significant heterogeneity. Type of diabetic model was found to be the prominent covariate that explained, at least partially, the heterogeneity. Moreover, diabetic rodents treated with Arctium lappa Lam. showed a notable improvement in their hypertriglyceridemia and hypercholesterolemia. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

12 pages, 1121 KiB  
Review
Anticancer Properties of Aqueous Extracts from Leguminosae
by Luca Serventi, Xuanyi Cai, Ruitian Chen, Nadeesha Dilrukshi, Jingyi Su, Refi Priskila Novaleta Tuange and Elizabeth Eilidh Ham
Nutraceuticals 2022, 2(4), 323-334; https://doi.org/10.3390/nutraceuticals2040025 - 1 Nov 2022
Cited by 4 | Viewed by 3333
Abstract
Inflammation and cancer are diseases caused by genetic and environmental factors as well as altered microbiota. Diet plays a role, with leguminous such as beans (Phaseolus vulgaris, Vicia faba), chickpeas (Cicer arietinum), lentils (Lens culinaris), peas [...] Read more.
Inflammation and cancer are diseases caused by genetic and environmental factors as well as altered microbiota. Diet plays a role, with leguminous such as beans (Phaseolus vulgaris, Vicia faba), chickpeas (Cicer arietinum), lentils (Lens culinaris), peas (Pisum sativum) and soybeans (Glycine max), known to prevent such diseases. Processing of food leguminous yields aqueous side streams. These products are nothing short of water extracts of leguminous, containing albumin, globulin, saponins, and oligosaccharides. This review analysed the most recent findings on the anticancer activities of legume-soluble nutrients. Albumin from chickpeas and peas inhibits the pro-inflammatory mediator interleukins, while soy Bowman–Birk Inhibitor inhibits serine proteases. The peptide vicilin activates peroxisome proliferator-activated receptor, mediating triglyceride metabolism. Soyasaponins promote apoptosis of cancer cells by activating caspases and by enhancing the concentration of intracellular calcium. Soyasapogenol regulates specific protein pathways, leading to apoptosis. Oligosaccharides such as raffinose and stachyose promote the synthesis of short chain fatty acids, balancing the intestinal microbiota, as result of their prebiotic activity. Verbascoside also modulate signalling pathways, leading to apoptosis. In closing, water extracts of leguminous have the potential to be efficient anticancer ingredients, by means of numerous mechanisms based on the raw material and the process. Full article
(This article belongs to the Special Issue Natural Nutraceuticals in Actual Therapeutic Strategies)
Show Figures

Graphical abstract

Back to TopTop